TBIO (Codex DNA) Rentabilitas dodolan miturut bathi reged

Lambang korporat lan logo Telesis Bio, Inc (TBIO)

Telesis Bio, Inc. (TBIO) leads in synthetic biology automation through its BioXp station and extensive R&D expenditures. Gross margin correlates with the adoption rate of benchtop synthesizers and demand for genetic engineering, while the 29.40 metric determines the status of the profitability parameter. The company's operations are strictly limited by FDA medical regulations and biomaterial disposal rules.

TBIO - Margin reged Telesis Bio ing rentang 28.04.2023 - 05.10.2024

Rincian metrik komprehensif lan analitis Codex DNA (TBIO)

Pambiji fundamental:Telesis Bio, TBIO
Produk seri Telesis Bio Inc.

Telesis Bio, Inc. (TBIO) leadership in synthetic biology automation via the BioXp station requires strict control over direct production costs. Gross margin measures the portion of revenue remaining after deducting the cost of goods sold, reflecting the efficiency of scaling technological innovations and the issuer's pricing power. An analysis of gross income allows an investor to assess the company's ability to convert R&D investments into operating profit.

Pesaing langsung

Tingkat bathi miturut bathi reged Tempus AI Inc|QGEN (Qiagen NV) - Margin reged|Tingkat bathi miturut bathi reged Ionis Pharma (IONS)|Rentabilitas reged Repligen Corp (RGEN)|RNA - Margin bathi reged|crisprtx.com - Tingkat bathi miturut bathi reged|Tingkat bathi reged WGS|RARE - Rentabilitas reged|Beam Tx (BEAM) - Tingkat bathi miturut bathi reged|SRPT (Sarepta Therapeutics Inc) - Tingkat bathi miturut bathi reged|TWST: Rasio bathi reged|TXG (10xgenomics.com) - Margin reged|NTLA (Intellia Therapeutics, Inc.) - Rasio bathi reged|Rentabilitas reged Stoke Corp (STOK)|Rentabilitas dodolan miturut bathi reged BioLife|Margin reged WVE (Wave Life Sciences Ltd)|MAZE: Rentabilitas dodolan reged|Sionna Therapeutics, Inc. - Margin reged|Tingkat bathi reged PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Tingkat bathi miturut bathi reged|QURE - Rentabilitas dodolan miturut bathi reged|MGTX (MeiraGTx Corp) - Margin reged|Margin bathi reged REGENXBIO Inc. RGNX|Rentabilitas reged Solid Biosciences (SLDB)|Ocugen Corp - Rentabilitas dodolan reged|Rentabilitas reged Pacific Biosciences PACB|Rasio bathi reged BNTC (Benitec)|Design Corp - Margin reged|Rocket Pharmaceuticals - Rasio bathi reged|Rentabilitas dodolan reged 4D Molecular Therapeutics, Inc.|Margin bathi reged Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Margin reged|Margin bathi reged Editas EDIT|Margin reged SLN|ProQR Therapeutics - Rentabilitas dodolan reged|Margin reged CDXS (Codexis, Inc.)|SGMO: Rentabilitas dodolan reged|Nautilus Biotechnology - Margin reged|Tingkat bathi reged MGX (Metagenomi, Inc)|DTIL: Margin reged|GBIO: Rasio bathi reged|Rentabilitas reged Boundless Bio Inc.|Tingkat bathi miturut bathi reged Exicure (XCUR)|Margin reged IMNN|PHIO (Phio Pharmaceuticals Corp.) - Tingkat bathi reged|Mustang Bio, Inc. - Tingkat bathi miturut bathi reged|RNAZ - Tingkat bathi miturut bathi reged|BNGO: Tingkat bathi miturut bathi reged|APDN (Applied DNA Sciences Inc) - Rentabilitas dodolan reged|BLUE (Bluebird Bio) - Tingkat bathi miturut bathi reged|ImmunoPrecise Antibodies Ltd - Tingkat bathi reged|OMGA (Omega Therapeutics Inc) - Margin reged|Rentabilitas reged OMIC|Rentabilitas reged Regulus Therapeutics Inc. (RGLS)|Tingkat bathi miturut bathi reged Syros Pharmaceuticals, Inc. SYRS|Rentabilitas reged TRACON TCON|Unity Biotechnology, Inc - Rentabilitas reged